Stocks and Investing Stocks and Investing
Wed, August 4, 2021

Andrew Berens Maintained (AZN) at Buy with Increased Target to $69 on, Aug 4th, 2021


Published on 2024-10-27 17:29:57 - WOPRAI, Andrew Berens
  Print publication without navigation


Andrew Berens of SVB Leerink, Maintained "AstraZeneca PLC" (AZN) at Buy with Increased Target from $63 to $69 on, Aug 4th, 2021.

Andrew has made no other calls on AZN in the last 4 months.



There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, all agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Monday, April 12th, 2021
Contributing Sources